wound care

Spectral AI Names Former Top MiMedx Financial Exec as CFO

by | Dec 27, 2023

Seasoned financial executive Peter M. Carlson has been hired as chief financial officer of Dallas-based Spectral AI Inc., an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care.

Carlson will succeed Nils Windler, who will remain with Spectral AI to work closely with Carlson, support an orderly transition of responsibilities, and provide financial accounting support to the company....

Spectral AI Appoints Chairman of Board’s Executive Committee
by | Dec 1, 2023

Dallas-based predictive artificial intelligence company Spectral AI Inc. announced that Erich Spangenberg has been appointed to the company’s board of directors and named chairman of its executive committee.

Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in clinical wound care.

“We are pleased to welcome the return of Erich to the board of directors, where his experience, insights and network will be an invaluable resource for our company,” Spectral AI CEO Wensheng Fan said in a statement....

Spectral AI Names EVP to Spearhead UK Subsidiary, Global Expansion of Imaging Tech
by | Oct 27, 2023
Spectral AI has recently secured its largest contract to date from the U.S. government, an award exceeding $149 million, boosting its total U.S. government awards accrued since 2019 to more than $246 million, as it aims to revolutionize wound care. The company's DeepView SnapShot Wound Imaging System, has received UK Conformity Assessed (UKCA) marking for use in the United Kingdom and has been classified as a Class 1 medical device by U.S. FDA.
Spectral AI Appoints ‘High-Impact’ Healthcare Exec to its Board of Directors
by | Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.